Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Total recalls
6,317
Class I (high risk)
150
Currently ongoing
692
Most recent
Sep 15, 2026

Most-cited firms for this cause

  • The Compounding Pharmacy of America383
  • Central Admixture Pharmacy Services, Inc.269
  • Franck's Lab Inc., d.b.a. Franck's Compounding Lab198
  • First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy140
  • Altaire Pharmaceuticals, Inc.135
  • Vita Pharmacy, LLC dba Talon Compounding Pharmacy130
  • Martin Avenue Pharmacy, Inc.118
  • Assurance Infusion118
Class I · High risk

Epinephrine Injection

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Ongoing Sterility / contamination American Regent, Inc. NDC 0517-3030-01 D-0865-2026
Class II · Moderate risk

BD ChloraPrep Clear

Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0690-2026